A new treatment for thrombosis, one of the first commercial applications for stem cells, and single-step ‘smart’ microcapsules which could deliver sustained release of drugs for up to six months are just some of the technologies being developed by new companies based on Cambridge research, with funding support from the University seed funds.
Image: www.enterprise.cam.ac.u
